Latest: FDA Approves New Biosimilar for Oncology Treatment

Advancing Equitable Access to Targeted and Immuno-Oncology Therapies in SCLC: Angel Qin, MD

11 August, 2025

0 Mins

Recent clinical trials like ADRIATIC and IMforte are shaping the future of small cell lung cancer (SCLC) treatment, explained Angel Qin, MD. She also emphasized the growing role of immunotherapy in adjuvant and maintenance therapies.

Tags:

Author

American Journal Managed Care

STAT+: Kennedy’s rejection of mRNA vaccines thwarts scientific progress — and threatens national security, experts say

FDA Accepts NDA for New Formulation of PSMA PET Injection in Prostate Cancer

📢

300x250 Banner

Advancing Equitable Access to Targeted and Immuno-Oncology Therapies in SCLC: Angel Qin, MD

Tags:

American Journal Managed Care

STAT+: Kennedy’s rejection of mRNA vaccines thwarts scientific progress — and threatens national security, experts say

FDA Accepts NDA for New Formulation of PSMA PET Injection in Prostate Cancer

Recent Content

COPD Biologics: Early Treatment Insights

Antihypertensive Medication Guidelines

Juvenile Arthritis Care Transition